4 years safety of fingolimod in real world: PANGAEA, a non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice

被引：0
|
作者：
Ziemssen, T.
Albrecht, H.
Haas, J. [1 ]
Klotz, L. [2 ]
Lang, M. [3 ]
Lassek, C.
Schmidt, S.
Tackenberg, B. [4 ]
Cornelissen, C.
机构：
[1] Jud Krankenhaus, Berlin, Germany
[2] Unilkin Munster, Klin Allgemeine Neurol, Munster, Germany
[3] NTD Study Grp, Ulm, Germany
[4] Univ Klinikum Giessen & Marburg, Marburg, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P21143
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [31] The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
    Biernacki, Tamas
    Sandi, Daniel
    Fuvesi, Judit
    Fricska-Nagy, Zsanett
    Kincses, Tamas Zsigmond
    Acs, Peter
    Rozsa, Csilla
    Dobos, Eniko
    Cseh, Botond
    Horvath, Laszlo
    Nagy, Zsuzsanna
    Csanyi, Attila
    Kovacs, Krisztina
    Csepany, Tunde
    Vecsei, Laszlo
    Bencsik, Krisztina
    PLOS ONE, 2022, 17 (04):
  • [32] Safety and Effectiveness of Fingolimod in Real-World Multiple Sclerosis Portuguese Patients
    Ribeiro de Barros, Ariana Helena
    Fiadeiro Sequeira, Joao Paulo
    Lopes de Sousa, Ary Severino
    Chegancas Capela, Carlos Miguel
    Gomes Pedrosa, Rui Manuel
    dos Santos Manita, Manuel Alexandre
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (04) : 129 - 135
  • [33] PANGAEA: the average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 695 - 695
  • [34] PANGAEA: The average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Klotz, L.
    Schmidt, S.
    Schwarz, H-J
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 620 - 620
  • [35] Retrospective, Non-interventional, Multi-centre Study Evaluating Safety of Fingolimod in Patients with Multiple Sclerosis in Taiwan
    Yang, C. C.
    Ro, L. S.
    Tsai, N. W.
    Lin, C. C.
    Huang, W. N.
    Tsai, C. P.
    Lin, T. S.
    Su, J. J.
    Huang, C. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 459 - 459
  • [36] Study design and first results of a non-interventional registry study to establish long-term safety and pharmaco-economic data on fingolimod (Gilenya®) in multiple sclerosis patients in Germany (PANGAEA)
    Ziemssen, T.
    van Lokven, T.
    Kempcke, R.
    Meergans, M.
    JOURNAL OF NEUROLOGY, 2012, 259 : S72 - S72
  • [37] Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)
    Ziemssen, Tjalf
    van Lokven, Tom
    Kempke, Raimar
    Meergans, Matthias
    NEUROLOGY, 2012, 78
  • [38] Effectiveness and Safety of Fingolimod in Patients Switching from Dimethy Fumarate, Teriflunomide, and Daclizumab in Daily Clinical Routine: Interim Results from PANGAEA 2.0
    Ziemssen, Tjalf
    Ettle, Benjamin
    Schulze-Topphoff, Ulf
    NEUROLOGY, 2019, 92 (15)
  • [39] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [40] Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
    Ziemssen, Tjalf
    Lang, Michael
    Schmidt, Stephan
    Albrecht, Holger
    Klotz, Luisa
    Haas, Judith
    Lassek, Christoph
    Lang, Stefan
    Winkelmann, Veronika E.
    Ettle, Benjamin
    Schulze-Topphoff, Ulf
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3276 - 3285
12345